Risk of ischemia in glioma surgery: Comparison of first and repeat procedures

Journal of Neuro-Oncology

Volumn 107, Issue 3, 2012, Pages 599-607

  Dützmann, Stephan ^a   Geßler, Florian ^a   Bink, Andrea ^a   Quick, Johanna ^a   Franz, Kea ^a   Seifert, Volker ^a   Senft, Christian ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

DWI lesion; Glioma; Infarction; Repeat surgery; Retrospective analysis

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CANCER GRADING; CANCER SURGERY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DATA BASE; DIFFUSION WEIGHTED IMAGING; FIRST SURGERY; GLIOMA; HUMAN; INSULA; KARNOFSKY PERFORMANCE STATUS; MULTIMODALITY CANCER THERAPY; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPERCULUM (BRAIN); PATIENT IDENTIFICATION; PEROPERATIVE COMPLICATION; PRIMARY TUMOR; REPEAT SURGERY; SURGERY; SURGICAL RISK; TEMPORAL LOBE; TUMOR LOCALIZATION; TUMOR RECURRENCE; TUMOR VOLUME; BRAIN TUMOR; FEMALE; INCIDENCE; MALE; MIDDLE AGED; NEUROSURGERY; PATHOLOGY; POSTOPERATIVE COMPLICATION; REOPERATION; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN NEOPLASMS; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLIOMA; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEUROSURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; REOPERATION; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84859704242     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-011-0784-1     Document Type: Article

References (38)

1. Schafer N, Tichy J, Thanendrarajan S, Kim Y, Stuplich M, Mack F, Rieger J, Simon M, Scheffler B, Bostrom J, Steinbach JP, Herrlinger U, Glas M (2011) Ifosfamide, carboplatin and etoposide in recurrent malignant glioma. Oncology 80(5-6):330-332
2. Gilbert MR, Kuhn J, Lamborn KR, Lieberman F, Wen PY, Mehta M, Cloughesy T, Lassman AB, Deangelis LM, Chang S, Prados M (2011) Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery. J Neurooncol (Epub ahead of print)
3. Nieder C, Astner ST, Mehta MP, Grosu AL, Molls M (2008) Improvement, clinical course, and quality of life after palliative radiotherapy for recurrent glioblastoma. Am J Clin Oncol 31(3): 300-305
4. Mandl ES, Dirven CM, Buis, Postma TJ, Vandertop WP (2008) Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy. Surg Neurol 69(5):506-509. doi:10.1016/j.surneu.2007.03.043 discussion 509
5. Easaw JC, Mason WP, Perry J, Laperriere N, Eisenstat DD, Del Maestro R, Belanger K, Fulton D, Macdonald D (2010) Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme. Curr Oncol (Toronto, Ont) 18(3):e126-e136
6. Barbagallo GM, Jenkinson MD, Brodbelt AR (2008) 'Recurrent' glioblastoma multiforme, when should we reoperate? Br J Neurosurg 22(3):452-455. doi:10.1080/02688690802182256
7. Terasaki M, Ogo E, Fukushima S, Sakata K, Miyagi N, Abe T, Shigemori M (2007) Impact of combination therapy with repeat surgery and temozolomide for recurrent or progressive glioblastoma multiforme: a prospective trial. Surg Neurol 68(3):250-254
8. Tofilon PJ, Fike JR (2000) The radioresponse of the central nervous system: a dynamic process. Radiat Res 153(4):357-370
9. Hwang SY, Jung JS, Kim TH, Lim SJ, Oh ES, Kim JY, Ji KA, Joe EH, Cho KH, Han IO (2006) Ionizing radiation induces astrocyte gliosis through microglia activation. Neurobiol Dis 21(3): 457-467
10. Bernstein M, Gutin PH (1981) Interstitial irradiation of brain tumors: a review. Neurosurgery 9(6):741-750
11. Quant EC, Drappatz J, Wen PY, Norden AD (2010) Recurrent high-grade glioma. Curr Treat Options Neurol 12(4):321-333
12. Chang SM, Parney IF, McDermott M, Barker FG 2nd, Schmidt MH, Huang W, Laws ER Jr, Lillehei KO, Bernstein M, Brem H, Sloan AE, Berger M (2003) Perioperative complications and neurological outcomes of first and second craniotomies among patients enrolled in the Glioma Outcome Project. J Neurosurg 98(6):1175-1181. doi:10.3171/jns.2003.98.6.1175
13. Xu JF, Fang J, Shen Y, Zhang JM, Liu WG, Shen H (2011) Should we reoperate for recurrent high-grade astrocytoma? J Neurooncol 105(2):291-299
14. Combs SE, Thilmann C, Edler L, Debus J, Schulz-Ertner D (2005) Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution. J Clin Oncol 23(34):8863-8869
15. Bauman GS, Sneed PK, Wara WM, Stalpers LJ, Chang SM, McDermott MW, Gutin PH, Larson DA (1996) Reirradiation of primary CNS tumors. Int J Radiat Oncol Biol Phys 36(2): 433-441
16. Veninga T, Langendijk HA, Slotman BJ, Rutten EH, van der Kogel AJ, Prick MJ, Keyser A, van der Maazen RW (2001) Reirradiation of primary brain tumours: survival, clinical response and prognostic factors. Radiother Oncol 59(2):127-137
17. Brandes AA, Franceschi E, Tosoni A, Bartolini S, Bacci A, Agati R, Ghimenton C, Turazzi S, Talacchi A, Skrap M, Marucci G, Volpin L, Morandi L, Pizzolitto S, Gardiman M, Andreoli A, Calbucci F, Ermani M (2010) O(6)-methylguanine DNAmethyl-transferase methylation status can change between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications. Neurooncology 12(3):283-288
18. Felsberg J, Thon N, Eigenbrod S, Hentschel B, Sabel MC, Westphal M, Schackert G, Kreth FW, Pietsch T, Loffler M, Weller M, Reifenberger G, Tonn JC (2011) Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas. Int J Cancer 129(3):659-670
19. Helseth R, Helseth E, Johannesen TB, Langberg CW, Lote K, Ronning P, Scheie D, Vik A, Meling TR (2010) Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol Scand 122(3):159-167
20. Clarke Dagger JL, Ennis Dagger MM, Yung WK, Chang SM, Wen PY, Cloughesy TF, Deangelis LM, Robins HI, Lieberman FS, Fine HA, Abrey L, Gilbert MR, Mehta M, Kuhn JG, Aldape KD, Lamborn KR, Prados MD (2011) Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma? Neurooncology 13(10):1118-1124
21. Park JK, Hodges T, Arko L, Shen M, Dello Iacono D, McNabb A, OlsenBaileyN,KreislTN, Iwamoto FM, Sul J,Auh S, ParkGE, Fine HA, Black PM (2010) Scale to predict survival after surgery for recurrent glioblastoma multiforme. J Clin Oncol 28(24):3838-3843
22. Ulmer S, Braga TA, Barker FG 2nd, Lev MH, Gonzalez RG, Henson JW (2006) Clinical and radiographic features of peritumoral infarction following resection of glioblastoma. Neurology 67(9):1668-1670
23. Smith JS, Lin H, Mayo MC, Bannerjee A, Gupta N, Perry V, Cha S (2006) Diffusion-weighted MR imaging abnormalities in pediatric patients with surgically treated intracranial mass lesions. J Neurooncol 79(2):203-209
24. Smith JS, Cha S, Mayo MC, McDermott MW, Parsa AT, Chang SM, Dillon WP, Berger MS (2005) Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. J Neurosurg 103(3): 428-438
25. Barker FG 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB (1998) Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42(4):709-720 discussion 720-703
26. Nimsky C, Ganslandt O, Tomandl B, Buchfelder M, Fahlbusch R (2002) Low-field magnetic resonance imaging for intraoperative use in neurosurgery: a 5-year experience. Eur Radiol 12(11): 2690-2703
27. Sawaya R, Hammoud M, Schoppa D, Hess KR, Wu SZ, Shi WM, Wildrick DM (1998) Neurosurgical outcomes in a modern series of 400 craniotomies for treatment of parenchymal tumors. Neurosurgery 42(5):1044-1055 discussion 1055-1046
28. Vives KP, Piepmeier JM (1999) Complications and expected outcome of glioma surgery. J Neurooncol 42(3):289-302
29. Khan RB, Gutin PH, Rai SN, Zhang L, Krol G, DeAngelis LM (2006) Use of diffusion weighted magnetic resonance imaging in predicting early postoperative outcome of new neurological deficits after brain tumor resection. Neurosurgery 59(1):60-66 discussion 60-66
30. Kumabe T, Higano S, Takahashi S, Tominaga T (2007) Ischemic complications associated with resection of opercular glioma. J Neurosurg 106(2):263-269
31. Sanai N, Polley MY, Berger MS (2010) Insular glioma resection: assessment of patient morbidity, survival, and tumor progression. J Neurosurg 112(1):1-9
32. Simon M, Neuloh G, Lehe M, Meyer B, Schramm J (2009) Insular gliomas: the case for surgical management. J Neurosurg 110(4):685-695
33. Smith GC, Pell JP (2003) Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ (Clinical research ed) 327(7429):1459-1461
34. Lutsep HL, Albers GW, DeCrespigny A, Kamat GN, Marks MP, Moseley ME (1997) Clinical utility of diffusion-weighted magnetic resonance imaging in the assessment of ischemic stroke. Ann Neurol 41(5):574-580
35. Nonaka H, Akima M, Hatori T, Nagayama T, Zhang Z, Ihara F (2003) Themicrovasculature of the cerebral whitematter: arteries of the subcortical white matter. J Neuropathol Exp Neurol 62(2): 154-161
36. Sanai N, Berger MS (2010) Intraoperative stimulation techniques for functional pathway preservation and glioma resection. Neurosurg Focus 28(2):E1
37. Wiedemayer H, Fauser B, Sandalcioglu IE, Schafer H, Stolke D (2002) The impact of neurophysiological intraoperative monitoring on surgical decisions: a critical analysis of 423 cases. J Neurosurg 96(2):255-262
38. Senft C, Bink A, Franz K, Vatter H, Gasser T, Seifert V (2011) Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial. Lancet Oncol 12(11):997-1003